Bupropion SR Plus Counseling for Smoking Cessation
NCT01621009 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 463
Last updated 2016-01-27
Summary
The purpose of this study was to determine if bupropion plus counseling was more effective than bupropion alone or counseling alone in helping smokers quit smoking.
Conditions
- Tobacco Dependence
- Smoking
Interventions
- DRUG
-
Active bupropion + counseling
Medications-Pre-quit: 150 mg bupropion per day 7 days before quit attempt, then 150 mg twice daily for 4 days before quit attempt; then 150 mg bupropion twice daily for eight weeks. Counseling-Pre-quit: two 10 minutes sessions before quit date; eight 10-minute sessions post quit date.
- DRUG
-
Active bupropion, No counseling
Medication - 150 mg bupropion per day starting week before quit day, then 150 mg twice daily 3 days before quit day, then 150 mg twice daily for eight weeks after quit day. Counseling: No cessation counseling, only medication checks
- DRUG
-
Placebo medication + counseling
Placebo bupropion once daily 7 days before quit day, then twice daily 4 days before quit attempt, then twice daily for 8 weeks after quit day. Counseling: Two 10-minutes sessions before quit day, then eight 10-minutes sessions for eight weeks after quit day.
- DRUG
-
Placebo medication, No counseling
Pre-quit: Placebo medication once daily 7 days before quit day, then twice daily before quit day, then twice daily for 8 weeks after quit day. Counseling: No counseling, just medication checks
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
National Institute on Drug Abuse (NIDA)
collaborator NIH -
University of Wisconsin, Madison
lead OTHER
Principal Investigators
-
Timothy B Baker, PhD · University of Wisconsin, Madison
-
Timothy B Baker, PhD · University of Wisconsin, Madison
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2001-01-31
- Primary Completion
- 2002-10-31
- Completion
- 2003-10-31
Countries
- United States
Study Locations
More Related Trials
-
Bupropion Treatment for Youth Smoking Cessation
NCT00344695 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Bupropion SR and Placebo for Smoking Cessation
NCT00176449 ·Status: COMPLETED ·Phase: PHASE4
-
Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms
NCT00332644 ·Status: COMPLETED ·Phase: PHASE4
-
Bupropion in Helping Adults Stop Smoking
NCT00534001 ·Status: COMPLETED ·Phase: PHASE2
-
Bupropion as a Smoking Cessation Aid in Alcoholics
NCT00044434 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Pharmacotherapy to Reduce Cue-responsiveness in Smokers
NCT00133757 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study of SR Bupropion for Adolescent Smoking Cessation
NCT00819078 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects
NCT06254001 ·Status: RECRUITING ·Phase: PHASE4
-
Bupropion as an Adjunct to the Nicotine Patch Plus CBT
NCT00142831 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking
NCT00248118 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Effectiveness of Bupropion for Smokers Recovering From Alcohol Dependence
NCT00304707 ·Status: COMPLETED ·Phase: PHASE3
-
Combined Pharmaco/Behavior Therapy in Adolescent Smokers
NCT00330187 ·Status: COMPLETED ·Phase: PHASE2
-
Bupropion and Cigarette-Related Cues in Smokers
NCT03920319 ·Status: COMPLETED ·Phase: PHASE1
-
Comparing Smoking Treatment Programs for Lighter Smokers - 1
NCT00086411 ·Status: COMPLETED ·Phase: PHASE2
-
Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia
NCT01576640 ·Status: TERMINATED ·Phase: PHASE4
-
Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking
NCT00033592 ·Status: COMPLETED ·Phase: PHASE3
-
Bupropion for Smoking Cessation During Pregnancy
NCT01390246 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation
NCT00419731 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
High Dose Bupropion for Smoking Cessation - Pilot Study
NCT03326128 ·Status: TERMINATED ·Phase: PHASE2
-
Concurrent Bupropion / Varenicline for Smoking Cessation
NCT01303861 ·Status: COMPLETED ·Phase: PHASE3
-
Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers
NCT01048944 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia
NCT00218231 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Nicotine Dependence and Acute Depression
NCT00186446 ·Status: COMPLETED ·Phase: PHASE4
-
Non-Nicotine Agents for Smoking Cessation
NCT00108537 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacologic Relapse Prevention for Alcoholic Smokers
NCT00000457 ·Status: COMPLETED ·Phase: PHASE2